Search Videos and More
San Antonio Breast Cancer 2025 Review Virtual Symposium
January 31, 2026The Benefits of Early Lung Cancer Screening: A Thoracic Surgeon’s Perspective on Early Detection and Collaborative Care
November 19, 2025Updates in Genitourinary Oncology
This annual conference hosts distinguished faculty who are leaders in prostate, bladder, sexual health, and kidney cancer. They will present major advances in the care of urologic cancers in 2025. Target Audience: Medical oncologists, urologists, radiation oncologists, internists, family practitioners, and other physicians, nurses, and allied health professionals Objectives:At the end of the session, participants should be able to: Review latest advances in kidney cancer, prostate cancer, and bladder cancer Review advances in sexual health urology and prevention of sexual dysfunction after prostate cancer therapy Be familiar with the appropriate use and expected toxicity profiles of novel treatment modalities for urologic cancersPost-ASCO 2025 Virtual Oncology Review
This annual symposium welcomes a distinguished faculty summarizing the latest advances in oncology and cancer research presented at this year’s annual American Society of Clinical Oncology (ASCO) meeting. Objectives At the end of the session, participants should be able to:Review latest advances in cancer research presented at the ASCO Annual MeetingLearn the optimal roles of novel diagnostics and treatments for patients with cancerReview breakthroughs in cancer therapies.Interventional Pulmonology at Atlantic Health, Where Precision Diagnostics Meets Patient-Centered Care
At Morristown and Overlook Medical Centers, robotic bronchoscopy and multidisciplinary collaboration are redefining what’s possible for patients with suspected lung cancer.Atlantic Health System and Atlantic Center for Research Deliver New Chapter in Bladder Cancer Care
Dr. Sandip Prasad leads an international trial that brings new bladder-sparing therapy to patientsMorristown Medical Center First in New Jersey to Offer Nonsurgical Ablation Technique for Advanced Lung Cancer
Atlantic Health’s Morristown Medical Center is the first hospital in New Jersey to offer patients a new, minimally invasive option to treat advanced lung cancer. The procedure couples technology from the Aliya™ Pulsed Electric Field (PEF) Energy Platform with a robotic Ion Bronchoscopy.Overlook Medical Center: Theranostics is Making Big Leaps in Personalized Cancer Care
Cancer care is evolving rapidly, and Overlook Medical Center is ushering in an exciting era in precision oncology. By investing in theranostics, a groundbreaking approach that combines diagnostic imaging and targeted therapy, Atlantic Healt is delivering best-in-class treatment while setting a new standard for personalized cancer care.Precision Oncology in Practice: How Theranostics Personalizes Treatment
In precision oncology, theranostics stands out as a transformative approach that tailors cancer treatment to the unique molecular profile of each patient. By integrating advanced diagnostic imaging with targeted therapy, theranostics ensures that treatments are customized to the unique characteristics of each patient's cancer, thereby optimizing efficacy and minimizing adverse effects.Theranostics: A New Frontier in Cancer Treatment at Overlook Medical Center
In the field of oncology, the pursuit of treatments that are both effective and minimally invasive has led to groundbreaking innovations. This includes advancements is theranostics, a fusion of therapy and diagnostics that is transforming cancer care. At the forefront of this medical evolution is Overlook Medical Center, where experts like James Cassuto, MD, PhD are successfully pioneering the integration of theranostics into patient care.Targeting Cancer: The Science and Strategy Behind CAR-T Success
Discover how clinicians are driving meaningful change and revolutionizing patient careOverlook Medical Center Among First in the World to Utilize CYTALUX® to Light Up Cancer in Real Time During Surgery
Overlook Medical Center, a leading provider of health care in New Jersey, announces its use of CYTALUX®, the only FDA-approved fluorescent imaging technology to light up early-stage lung cancer during surgery — enhancing a surgeon’s ability to visualize cancer in real-time.